Hong Kong Tobacco Stock News

CLSA’s latest research highlights how Shanghai’s easing measures and Hong Kong’s tighter property policies could reshape real estate exposure, with Link Real Estate Investment Trust (SEHK:823) identified as a potential beneficiary of prospective REIT connect opportunities. See our latest analysis for Link Real Estate Investment Trust. At a current share price of HK$38.76, Link REIT’s 1 month share price return of 7.91% and year to date share price return of 10.11% sit alongside a 1 year total...

ESG recognition puts Fosun International in focus Fosun International (SEHK:656) is back on investors' radar after receiving the Certificate of Excellence in Environmental, Social and Governance Reporting from the Hong Kong Management Association, highlighting the depth of ESG integration in its group-wide strategy. See our latest analysis for Fosun International. The ESG recognition arrives after a volatile period, with a 1 day share price return of 7.5% lifting Fosun International to...

If you are wondering whether 361 Degrees International still offers good value after its recent share price move, or if much of the opportunity is already reflected in the price, this article is for you. The stock last closed at HK$5.65. It has returned 1.8% over the past 7 days, declined 1.7% over the past 30 days, gained 5.0% year to date, 47.0% over 1 year and 72.3% over 3 years, with a 5 year return of 194.4%. Recent coverage has focused on the company as investors look for ways to...

Plover Bay Technologies (SEHK:1523) just released its 2025 results, reporting higher revenue, net income and earnings per share, alongside increased dividends and a proposed spin off and Nasdaq listing of its connectivity subsidiary. See our latest analysis for Plover Bay Technologies. The strong 2025 update, higher ordinary and special dividends, and the planned Nasdaq spin off come after a 24.1% 1 month share price return and a 45.1% 3 month share price return, while the 1 year total...

Horizon Robotics (SEHK:9660) is back in focus as investors weigh very strong recent automotive AI revenue growth in relation to expectations for the 23 March 2026 earnings release and potential new OEM design wins in China. See our latest analysis for Horizon Robotics. At the latest share price of HK$8.21, Horizon Robotics has seen short term share price pressure, with a 7 day return of 7.75% and year to date share price return of 8.68%. The 1 year total shareholder return of 1.08% points to...

Recent environmental mandates and power rationing in China have capped Aluminum Corporation of China (SEHK:2600) domestic output, pushing the producer to focus on integrated bauxite-to-smelter projects in Indonesia and confronting EU carbon rules. See our latest analysis for Aluminum Corporation of China. At a latest share price of HK$14.14, Aluminum Corporation of China has a 90 day share price return of 34.8% and a very large 1 year total shareholder return, suggesting momentum has been...

Sinopec Kantons Holdings previously announced the liquidation of a joint venture and the disposal of related assets, reshaping its crude oil jetty and storage footprint. This move highlights how the company is reconfiguring its portfolio exposure to midstream infrastructure, potentially altering its role within regional oil logistics. We will now examine how the joint venture liquidation and asset disposal reshape Sinopec Kantons’ investment narrative and future business mix. Rare earth...

CLP Holdings Limited has released its audited full-year 2025 results, reporting revenue of HK$88,018 million and net profit of HK$10,667 million, both lower than the prior year, alongside earnings per share of HK$4.14 from continuing operations. Despite weaker earnings, the Board raised the total annual dividend to HK$3.20 per share and advanced its transition plans through new renewable projects, battery storage expansion, and the planned divestment of the Jhajjar coal-fired plant in...

What the EU approval could mean for Hansoh Pharmaceutical Group (SEHK:3692) The European Commission’s approval of Hansoh Pharmaceutical Group (SEHK:3692)’s Aumolertinib Mesylate Tablets for specific advanced non small cell lung cancer patients takes Ameile and Aumseqa beyond China and into a major new market. This decision, following a positive view from the European Medicines Agency’s Committee for Medicinal Products for Human Use, adds an EU indication for both first line EGFR mutated NSCLC...

What ZJLD’s profit warning means for shareholders ZJLD Group (SEHK:6979) has warned that 2025 revenue and profit are expected to fall by more than half, citing weaker baijiu demand and its own decision to cut channel inventory. At the same time, the company is pushing its Premier Retailers Alliance model and extending distribution into county and rural markets. It is aiming to reset how it reaches consumers and uses its sales network. See our latest analysis for ZJLD Group. Against this...

TCL Electronics Holdings (SEHK:1070) has been promoted to the Hang Seng Composite LargeCap & MidCap Index. This change can influence passive fund flows and investor attention around the stock. See our latest analysis for TCL Electronics Holdings. The index promotion comes after a period of firm share price momentum, with TCL Electronics Holdings posting a 90 day share price return of 20.16% and a year to date share price return of 17.29%. The 1 year total shareholder return stands at 79.59%...

The Hong Kong government recently raised stamp duty on residential properties valued above HK$100,000,000 to 6.5% and outlined plans to bring REITs under mutual-market access while potentially exempting some non-residential property transfers from stamp duty. These policy moves could reshape how developers like Hang Lung Properties balance high-end residential exposure with participation in an evolving REIT and commercial property framework. We’ll now examine how the higher stamp duty on...

SUNeVision Holdings (SEHK:1686) is back in focus after reporting half year results to December 31, 2025, with higher sales, net income and earnings per share, supported by demand for premium data centre capacity. See our latest analysis for SUNeVision Holdings. The latest results land after a strong run in the share price, with a 90 day share price return of 32.42% and a year to date gain of 41.60%, even though the 1 year total shareholder return is 21.68% lower. That mix points to momentum...

JNBY Design (SEHK:3306) is back in focus after reporting higher first half 2026 revenue, profit and margins, alongside stronger operating cash flow and a higher interim dividend that reinforces its emphasis on shareholder returns. See our latest analysis for JNBY Design. The latest set of results and dividend news comes after a period of positive market interest, with a 30 day share price return of 12.55% and a 1 year total shareholder return of 59.93%. The 3 year total shareholder return of...

Yangtze Optical Fibre and Cable recently announced it will showcase its latest AI‑oriented optical connectivity solutions at MWC Barcelona 2026, including a dedicated March 4 launch event for its hollow‑core fibre technology. This focus on hollow‑core fibre, which is designed to deliver lower latency, higher transmission efficiency and improved signal quality, highlights YOFC’s bid to support next‑generation ultra‑high‑speed data and AI computing networks. We’ll now examine how this...

WuXi XDC Cayman (SEHK:2268) just expanded its ADC platform reach as Earendil Labs secured an exclusive global license to the WuXiTecan-2 payload-linker technology, structured with upfront, milestone and royalty economics. See our latest analysis for WuXi XDC Cayman. The Earendil Labs agreement, which highlights WuXi XDC Cayman’s ADC and payload platform, comes as the shares trade at HK$63.15, with a 1 day share price return of 8.23%, a 30 day share price return of 2.02%, and a 1 year total...

Xinyi Glass Holdings (SEHK:868) has put fresh numbers on the table for FY 2025, with first half revenue of C¥9.8b and basic EPS of C¥0.23, setting the tone for how the rest of the year might shape up. The company has seen revenue move from C¥10.9b in the first half of 2024 to C¥9.8b in the latest half, while EPS has shifted from C¥0.59 to C¥0.23. These shifts sit against trailing twelve month EPS of C¥0.62 on revenue of C¥20.8b. With trailing net margin at 13.1% versus 15.1% a year earlier,...

Xiaomi has taken its tariff and royalty dispute to India's Supreme Court, challenging a tribunal ruling on how certain payments tied to imports should be taxed. The case centers on whether royalty payments linked to technology and brand use should be added to the customs value of imported components. The outcome could shape future tax treatment for contract manufacturing arrangements used by Xiaomi and other multinational producers in India. Xiaomi, traded as SEHK:1810, is contesting this...

Why the Crescent Biopharma partnership matters for Sichuan Kelun-Biotech Biopharmaceutical The new collaboration between Crescent Biopharma and Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) on next generation oncology drugs, including joint clinical trials, is drawing fresh attention from investors to Kelun-Biotech's pipeline and funding position. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. At the latest share price of HK$387.4, Sichuan Kelun-Biotech...

MiniMax Group stock moves after sharp month-long rally MiniMax Group (SEHK:100) has drawn fresh attention after a sharp move in its share price over the past month, prompting investors to reassess the newly listed AI foundation model developer. See our latest analysis for MiniMax Group. The latest pullback, including a 3.17% 1 day share price return decline and 21.29% 7 day share price return decline, comes after a 56.45% 30 day and 121.30% year to date share price return. This suggests...

Recent share move and business snapshot Ascentage Pharma Group International (SEHK:6855) has seen its share price move recently, with a 1 day return of about 1.4% and a decline of roughly 26.9% over the past 3 months, drawing attention to its clinical stage biotech profile. See our latest analysis for Ascentage Pharma Group International. Looking beyond the latest move, the share price has recorded a 4.9% decline over the past month and a 26.9% decline over the past quarter, while the 1 year...

CSPC Pharmaceutical Group (SEHK:1093) has received regulatory clearance for two long-acting drug candidates, including a monthly GLP-1/GIP injection in the US and a week-long ropivacaine pain therapy trial in China. See our latest analysis for CSPC Pharmaceutical Group. These trial approvals arrive after a strong 116.18% 1-year total shareholder return and a 25.16% 90-day share price return, although the 30-day share price return of 6.16% and recent 7-day weakness suggest shorter term...

JPMorgan’s upgrade of Cathay Pacific Airways (SEHK:293), which followed the expiry of its buyback plan on 24 February 2026, has put fresh attention on the airline’s balance sheet, cash generation, and sizeable aircraft commitments. See our latest analysis for Cathay Pacific Airways. At a share price of HK$14.06, Cathay Pacific’s recent 7 day share price return of 10.53% and 90 day share price return of 16.58% sit alongside a 1 year total shareholder return of 46.56%. This suggests momentum...

Grand Pharmaceutical Group (SEHK:512) has drawn investor attention after posting annual revenue of HK$11,704.979 million and net income of HK$2,079.449 million, putting fresh focus on how its diversified healthcare business is currently valued. See our latest analysis for Grand Pharmaceutical Group. At a share price of HK$7.83, Grand Pharmaceutical Group has seen short term share price pressure, with a 90 day share price return decline of 4.74%. However, its 1 year total shareholder return of...